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Abstract
Background: Obesity is a risk factor for mood disorder (such as depression and anxiety). We aimed to assess application of  A Body 
Shape Index (ABSI) and abdominal volume index (AVI), as new indices of  obesity to evaluate the relationship between obesity and 
depression/anxiety.   
Methods: This cross sectional study was conducted on 307 overweight and obese women (249 females, 58 males) 20-60 years in Iran 
in 2017-2018. The anthropometric measures including weight, waist circumference, hip circumference, body fat and derived values of  
body mass index, waist–hip ratio, AVI and ABSI were evaluated. HADS questionnaire for depression and anxiety completed.
Results: Prevalence of  depression was 36.1% in women; men 24.1%; overweight 28.1%; obese 36.5 % and central obesity 33.7%. 
Anxiety was apparent in 27.1% of  overweight 30.3 % obese and 29.6% central obesity. People with depression and anxiety had higher 
WC, BF and AVI. ABSI had no significant correlation with depression/anxiety. The odds of  depression (1.06; 95% CI, 1.02-1.12) and 
anxiety (1.06; 95% CI, 1.01-1.11) were elevated with increase AVI.  
Conclusion: Our results suggested that AVI as an indirect measure of  abdominal obesity along with WC and BF could be useful in 
predicting the relationship between obesity and depression/anxiety.  
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Introduction
Excessive body fat deposition which is defined as obesi-
ty has a dramatic growing trend worldwide and it could 
increase all-cause mortality1. Obesity is considered as a 
chronic and complex disease which contributes in a wide 
range of  adverse health outcomes such as cardiovascular, 
visual and psychiatric disorders2-4.
Depressive disorders are the major psychiatric problem 
worldwide which will account 11% of  total burden of  
disease by 2020 according to world health organization 
report5. The interrelationship between obesity and de-
pression frequently has been studied in the literature al-
though still it is not fully understood that how they are 
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linked? Some investigations suggest that depression is 
more prevalent among obese people particularly females 
while paradoxically there is some evidence linking obesity 
to lower degree of  depressive symptoms and anxiety6-8. 
However there are several proposed mechanisms on the 
pathways explaining the obesity and depression associa-
tion among them dysfunction in HPA axis has attracted 
much interest9,10. Actually it has been suggested that de-
pression and anxiety can induce the activity of  HPA axis 
which in turn increases adrenal cortisol secretion11. Some 
evidence has also supported the obesity, particularly ab-
dominal type, to be developed following over-activation 
of  HPA axis12.
Many studies seeking the correlation between obesity and 
depression/anxiety have used BMI as a predictor index 
of  higher fat accumulation while it has been confirmed 
that however BMI is the best tool for body fat estimation 
it has some limitations in indication of  how this fat mass 
is distributed over the body13. Some evidence account fat 
distribution particularly abdominal adiposity as a more 
predictive index for the association between obesity and 
diseases specially mood illnesses including depression 
and anxiety14. Zhao et al study suggested that abdominal 
obesity among overweight and obese individuals was sig-
nificantly associated with icreased depressive symptoms15. 
Lee et al reported that depressive mood is associated with 
visceral fat, not with subcutaneous fat, in overweight pre-
menopausal women16. There are some indices locating 
fat mass including Waist-height ratio (WHtR), Waist-hip 
ratio (WHR) and the newer ones like a body shape index 
(ABSI) and abdominal volume index (AVI)17,18. In current 
study we hypothesized that these new indices are more 




In the cross sectional study, participants selected by sim-
ple random sampling from Golestan referral and gov-
ernmental Hospital of  Ahvaz Jundishapur University 
of  Medical science in Ahvaz, Iran from October 2017 
to March 2018. Among eligible participants in this study, 
Forty-eight individuals, including Patients with psycho-
logical diseases other than depressive disorders and peo-
ple consuming alcohol or psychotropic drugs were ex-
cluded from our investigation. Finally, 307 individuals 
(249 females and 58 males) between 18 to 60 years of  age 
with BMI above 25 kg/m2 and history of  failure to lose 
extra body weights, to be enrolled to this study. The study 
was approved by the ethical committee of  AJA Universi-
ty of  Medical Sciences. At the beginning all the entrants 
completed written informed consent and another demo-
graphic questionnaire. Sample size was calculated accord-
ing to previous study15 and using the following formula:  
Sample size = D [Z2 1-α /2 × p × (1-p)] d2.
D= design effect of  2 was used to account for increased 
variance due to the cluster sampling technique. Z1-α = 
the   z-score corresponding to the desired confidence lev-
el of  the estimate. A 95% confidence level (95%CI) was 
chosen, corresponding to Z1-α = 1.96.
Body weight (to the nearest 0.1 kg) and standing height 
(to the nearest 0.1 cm) were measured (Inbody230, Bio-
space, Korea). The scale was calibrated before each mea-
surement. BMI was calculated with using weight (kg) di-
vided by height (m) squared. Waist circumferences (WC) 
and hip circumferences (HC) measurement was evaluated 
according to the protocol presented in another study19. 
The WHR was obtained by dividing WC to HC. A body 
shape index (ABSI) = WC/(BMI2/3 height1/2) and ab-
dominal volume index (AVI) = [2 cm (waist) 2+0.7 cm 
(waist-hip)2]/ 1,000,  are new indices of  body fat per-
centage and abdominal fat accumulation which we cal-
culated according to previous studies20,21. Moreover tetra 
polar Bioelectrical Impedance Analysis (BIA) was applied 
to evaluate body fat and lean body mass in participants. 
Evaluation of  depressive symptoms was done using Hos-
pital Anxiety and Depression Scale (HADS) which helps 
patients to assess their symptoms of  both depression and 
anxiety during the last week they passed by themselves. 
This scale is a questionnaire consists of  two groups of  
questions, seven for each part, indicating anxiety and 
depression in a clinical setting. Each subscale of  HADS 
has an overall score range 0 to 21 which the higher score 
indicates the higher severity of  anxiety or depression as 
follows: 0-7 no symptoms, 8-10 mild, 11-14 moderate 
and 14-21 severe22. An observer was used to evaluate the 
equipment, methods and assessment technics used in this 
study.  
Statistical analyses
All the analyses were performed using IBM SPSS statis-
tics for windows version 21.0 (IBM Corp, 2012). Kolm-
ogorov-Smirnov test was used to examine whether the 
variables have normal distribution or not. For compare 
means over two groups, Kruskal-Wallis and One-Way 
ANOVA tests were used. Chi square, Wilcoxon signed-
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rank and independent samples t tests were used to com-
pare means between groups. Spearman and Pearson tests 
were used to assess correlation markers for anthropomet-
ric measurements. P<0.05 was considered as statistical 
significant in all the analyses.   
Results
This study included 249 females and 58 males aged be-
tween 18 to 60 years (mean 39.98 ±11.77). We didn't 
have missing value in our study. Means of  calculated BMI 
and ABSI for all the participants were 32.83±5.06 and 
0.0100±0.002 respectively. We showed the distribution of  
the values as median for WC, percentage of  body fat, and 
AVI ( cm, 38.25% and 22.05 respectively). Table 1 has 
summarized analysis of  anthropometric measurements 
and adiposity indices among quartiles of  ABSI.
Table 1.  Anthropometric characteristic of participants for anxiety status according to HADS score 
 
Variables ABSI 
  Q1 Q2 Q3 Q3 P-V 
Age, years 39.3±11.2 39.1±10.9 40.7±11.7 40.6±13.1 0.75 
Weight (Kg) 107.6±15 90.4±9.3 81.4±7.2 72.5±7 <0.001 
BMI (kg/m2) 39.5±3.8 33.6±1.8 30.7±1.5 27.4±1.8 <0.001 
WC* (cm) 120 (111-127.75) 107 (100.5-113) 102 (98-107) 97.5 (92-103) <0.001** 
HC (cm) 119.7±11.3 111.6±8.3 108.4±6.2 103.8±5.9 <0.001 
WHR 1.00 ± 0.11 0.96 ± 0.09 0.94 ± 0.07 0.94 ± 0.08 <0.001 
BFP* 42.2 (38.3-44.9) 39.7 (35.1-41.7) 38.4 (35.2-39.9) 35 (31.8-36.9) <0.001** 
AVI 29 (24.6-32.6) 22.8 (20.2-25.5) 20.8 (22.8-19.2) 19 (16.9-21.2) <0.001** 
 
BMI; Body Mass Index, WC; Waist Circumference, HC; Hip Circumference, WHR; Waist–hip ratio, PBF; 
percentage body fat, ABSI; A Body Shape Index, AVI; abdominal volume index 
*These variables are expressed as median and interquartile range and others are expressed as mean ± SD. 
** P values were derived from Kruskal-Wallis and others from One-Way ANOVA. 
Characteristics of  the study population according to status 
of  depression using HADS-depression score are shown 
in Table 2. The results of  our study showed that 36.1% 
of  women and 24.1% of  men, 28.1% of  overweight and 
36.5 % of  obese subjects, 33.7% of  subjects with central 
obesity and 38.5% of  ones without central obesity had 
some degrees of  depression based on HADS-depression 
score. Moreover 76.6% of  people with depression had 
apparent symptoms of  anxiety which was proved using 
scores resulted from HADS-anxiety questionnaire (Table 
2).
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Table 2. Qualitative characteristics of study population according to status of anxiety and depression 
 
Variables Anxiety Depression 











Anxiety/ No, n (%) 182 
(89.7%) 
21 (10.3%) 0.001** 
182 (83.8%) 
35 (16.2%) 0.001** 
Depression Yes, n (%) 35 (33.7%) 69 (66.3%)   21 (23.3%) 69 (76.6%)   
Sex Male, n (%) 46 (79.3%) 12 (20.7%) 0.15 44 (75.9%) 14 (24.1%) 0.08 
  





159 (63.9%) 90 (36.1%) 
  
Age groups 






105 (66.5%) 53(33.5%) 
0.27 
  
40-< 60, n (%) 90 (69.2%) 
40 
(30.8%) 
  88(68.2%) 41 (31.8%)   
  ≥ 60, n (%) 14 (70.0%) 6 (30.0%)   10(50%) 10 (50%)   
BMI Overweight, n 
(%) 
70 (72.9%) 26 (27.1%) 0.47 69 (71.9%) 27 (28.1%) 0.15 
  






134 (63.5%) 77 (36.5%) 
  
WC No Central 
Obesity, n (%) 
19 (70.4%) 8 (29.6%) 0.28 8 (61.5%) 5 (38.5%) 0.72 







195 (66.3%) 99 (33.7%) 
  
 
BMI; Body Mass Index, WC; Waist Circumference 
*P -values were derived from chi square test 
The anthropometric measurements of  samples for status 
of  anxiety and depression according to HADS-anxiety 
score are presented in table 3. Application of  HADS-anx-
iety for seeking symptoms of  anxiety showed that 31.3% 
of  women and 20.7% of  men were anxious. Furthermore 
27.1% of  overweight and 30.3 % of  obese subjects, and 
also 29.6 % and 23.1% of  participants with or without 
central obesity experienced some degrees of  anxiety.
The investigation of  correlation between depression/
anxiety HADS scores and anthropometric indices mea-
surements indicated that people with anxiety had higher 
WC (107 vs. 103), percentage of  body fat (39 vs. 38.05) 
and AVI (22.89 vs. 21.21) compare to normal group. In 
addition, individuals with high score of  depression had 
higher WC (108 vs. 103) and AVI (23.32 vs. 21.21) com-
pare to normal individuals (Table 3).
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Variables Anxiety status Depression status 
  Normal (n=217) Anxious (n=90) P-V Normal (n=203) Depression (n=104) P-V 
Age (years) 40.02 ± 11.76 39.89 ± 11.92 0.91 39.85±11.69 40.24±12.03 0.79 
Weight 
(Kg) 
87.33 ± 16.31 89.67 ± 16.79 0.21 87.22±16.25 89.55±16.83 0.26 
BMI 
(kg/m2) 
32.59 ± 4.97 33.41 ± 5.26 0.23 32.51±5.11 33.46±4.69 0.14 
WC* (cm ) 103 (97-112) 107 (99-117.75) 0.02** 103(98-112) 108(98.25-119.25) 0.02** 
HC (cm) 110.27 ± 9.81 112.51 ± 10.38 0.08 110.26±10.09 112.22±9.78 0.11 
WHR 0.96 ± 0.10 0.97±0.09 0.43 0.95±0.09 0.97±0.09 0.41 




ABSI 0.01 ± 0.002 0.001 ± 0.002 0.75 0.0102±0.002 0.0098±0.002 0.35 






5 (3-6) 9 (8-12) 0.001** 3(2-5) 9(7-12) 0.001** 
 
BMI; Body Mass Index, WC; Waist Circumference, HC; Hip Circumference, WHR; Waist–hip ratio, PBF; percentage body fat, ABSI; A Body 
Shape Index, AVI; abdominal volume index 
*These variables are expressed as median and interquartile range and others are expressed as mean ± standard deviation 
** P -values were derived from Wilcoxon signed-rank and others from test independent t test 
Table 3. Demographic and anthropometric characteristic of participants for status of anxiety 
and depression according to HADS anxiety score 
Table 4 show the logistic regression analysis used to ex-
amine the relationship between anthropometric indexes 
and depression or anxiety. Depression and anxiety had a 
significant positive relationship with WC, BF, WHR and 
AVI. Table 5 show that the BMI, WC, BF, BF% have a 
significant correlation with AVI (positively) and ABSI 
(negatively).
We set median of  AVI as its cut off  and, accordingly, we 
performed regression analysis for other measurements as 
described in Table 4. Even after adjustment for age and 
height being obese (BMI more than 30 kg/m2) had the 
greatest effects on AVI and smallest effect belonged to 
being at a BMI ranges 25 to 29.9 kg/m2. 
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BMI; Body Mass Index, WC; Waist Circumference, HC; Hip Circumference, WHR; Waist–hip ratio, LBM; Lean 
Body Mass, PBF; percentage body fat, ABSI; A Body Shape Index, AVI; abdominal volume index, CI; Confidence 
interval 
 
P-Values were adjusted for age and gender 
Depression Anxiety Variables 
P-V CI OR P-V CI OR   
0.01 (1.003-1.037) 1.020 0.03 (1.002-1.037) 1.019 Weight (kg) 
0.11 (1.007-1.047) 1.036 0.05 (1.000-1.097) 1.047 Height (cm) 
0.01 (0.992-1.083) 1.027 0.007 (1.008-1.050) 1.028 WC (cm) 
0.34 (1.007-1.047) 1.013 0.25 (0.989-1.043) 1.016 HC (cm) 
0.001 (1.363-1.640) 1.495 0.001 (1.428-1.792) 1.600 Anxiety 
0.03 (1.003-1.072) 1.037 0.11 (0.993-1.063) 1.027 LBM (kg) 
0.04 (1.00-1.058) 1.029 0.02 (1.004-1.063) 1.033 BF (kg) 
0.22 (0.980-1.092) 1.034 0.08 (0.993-1.113) 1.052 PBF (%) 
0.08 (0.995-1.093) 1.043 0.13 (0.988-1.089) 1.038 BMI (kg/m2) 
0.005 (4.315-328.54) 119.044 0.006 (3.896-3652.5) 119.284 WHR 
0.19 (0.00-3.593E+16) 0.00 0.51 (0.0-4.1E+33) 0.000 ABSI 
0.01 (1.015-1.109) 1.061 0.009 (1.016-1.112) 1.063 AVI 
0.84 (0.281-2.82) 0.891 0.50 (0.419-5.929) 1.577 Central obesity 
Table 5. Correlation markers for anthropometric measurements 
Variables PBF* AVI* ABSI 
  R P-V R P-V r P-V 
PBF 1 NA 0.42 <0.001 -0.47 <0.001 
AVI 0.42 <0.001 1 NA -0.64 <0.001 
Height -0.48 <0.001 0.20 <0.001 0.09 <0.001 
Weight 0.28 0.001 0.77 <0.001 -0.80 <0.001 
BMI 0.62 <0.001 0.80 <0.001 -0.90 <0.001 
WC 0.43 <0.001 0.99 <0.001 -0.65 <0.001 
PBF; percentage body fat, AVI; abdominal volume index, BMI; Body Mass Index, WC; Waist Circumference, 
ABSI; A Body Shape Index, 
 
* These correlation are obtained from Spearman test and others from Pearson test 
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Discussion
There is a large body of  literature assessing the interrela-
tionship between obesity and mood disorders6,8,10. It has 
been suggested that there are a reciprocal link between 
depression /anxiety and obesity. A meta-analysis report-
ed that obesity increased the risk of  depression, and de-
pression increased the odds for developing obesity23. On 
the other hand, there are various tools and indicators 
with different performance for assessing obesity. Recent-
ly, many studies have been conducted to introduce the 
best anthropometric measure predicting the relationship 
between obesity and mood disorder such as depression 
and anxiety. 
In our study, we did not find any significant correlation 
between BMI and depression or anxiety. BMI is a con-
ventional and easy tool for indication of  overweight and 
obesity but it has some limitations include inability to 
differentiate the adipose tissue and lean body mass and 
also significant differences in the BMI efficiency between 
ethnic groups24,25. These limitations may be more in men 
due to higher muscle mass compare to women. Several 
studies reported that BMI was a significant predictor of  
depression in females but not in males26,27. It seems that 
other anthropometric indices are more effective to evalu-
ate the relationship between obesity and depression/ anx-
iety status. Similar to our findings, Guedes et al suggested 
that the body fat percentage and not BMI was associat-
ed with an increased severity of  anxiety and depressive 
symptoms based on HADS scores28.
Failing in indication of  body shape by the BMI formed 
the basics of  studies seeking new tools for locating body 
central fat including WC, ABSI and AVI. We hypothe-
sized that new anthropometric indices including AVI and 
ABSI could be more useful because of  the proposed 
ability to indicate abdominal fat accumulation. To the au-
thors’ knowledge this was the first investigation assessing 
the application of  ABSI and AVI in clarification of  rela-
tionship between obesity and depression or anxiety.
ABSI has obtained from standardization of  WC to weight 
and height and proposed as a new index for estimation of  
death hazard due to obesity. High values of  ABSI could 
imply that fat is over deposited in abdominal area and the 
fraction of  lean body mass is diminished in periphery20. 
In comparison to normal subjects neither for depression 
nor for anxiety, we observed difference in mean ABSI. 
Moreover ABSI had no significant correlation with BMI, 
BF, and BF% in our samples.
Our results also showed that AVI is higher in people 
with depression/anxiety. AVI takes place among the 
best indicators of  abdominal fat deposition29. In consis-
tent with the Ehrampoush et al. comparative study on 
various anthropometric tools for exploring adiposity we 
also suggest that AVI is strongly correlated with WC and 
BF which are predictive for accumulation of  fat mass in 
central area of  human body17. Abdominal adipose tissue 
induces immune system activation following release of  
cytokines and other regulatory molecules which in turn 
trigger inflammatory pathways in downstream30,31. De-
pression symptoms could be aggravated as a result of  
systemic inflammation so it has much of  importance 
to concentrate on central adiposity when we are talking 
about the relationship between obesity and depression/
anxiety32. Some other mechanisms have been suggested 
for the linkage between abdominal obesity and depres-
sion among them dysregulation of  hypothalamic-pitu-
itary-adrenocortical (HPA) axis resulted by reduction in 
glucocorticoid receptors (GR) and over secretion of  cor-
tisol could be emphasized33.
Our study had some limitations: The cross-sectional na-
ture of  this study made it difficult to conclude a causal 
relationship. Indeed it is not clearly understood whether 
depression or anxiety influenced the possibility of  over-
weight and obesity or people with high amount of  body 
fat appear with symptoms of  depression or anxiety. Sec-
ondly, we could not find any correlation between ABSI 
and depression which could partly be due to small num-
ber of  sample and confounders effect. Moreover it would 
be better if  we had a control group with normal BMI to 
find a dose response for observed relationship between 
abdominal obesity and depression/anxiety. To the best of  
our knowledge, the study was the first to report the rela-
tionship between depression/anxiety and AVI and ABSI 
in among overweight and obese women.
Conclusion
We concluded that AVI could be a better anthropometric 
measure for indication of  relationship between abdom-
inal obesity and depression/anxiety in a small popula-
tion. The continuing increases in the global prevalence 
of  overweight and obesity suggest that mental health sta-
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tus should be screened and evaluated in obese individuals 
especially people with central obesity. A routine anthro-
pometric index like BMI has some limitations to assess 
central obesity. Our results suggest that the AVI is useful 
for evaluating obesity in depression/anxiety.
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